小児ミトコンドリア病の診断スキームと新規遺伝子を含む最近の知見
Author:
Open Access
- 1 October 2023
- journal article
- research article
- Published by The Nihon University Medical Association in Journal of Nihon University Medical Association
- Vol. 82 (5) , 263-270
Abstract
The main function of mitochondria is to produce energy, and the respiratory chain complex embedded in theinner membrane of mitochondria is the site of energy production. Its disorder leads to dysfunction in variousorgans, a condition called mitochondrial respiratory chain complex deficiency (MRCD), or simply, mitochondrialdisease. Over 1,500 proteins are involved in respiratory chain reactions, and only 13 of them are encoded bymitochondrial DNA (mtDNA). The rest are coded by nuclear genes. Currently, there are more than 420 genes recognized to cause MRCD, and many of them are nuclear. MRCD caused by mtDNA mutations is maternally inherited, while that caused by nuclear genes is inherited in an autosomal recessive, autosomal dominant, or X-linkedmanner. Over 3,000 cases of pediatric MRCD have been analyzed in Japan since 2007, and over 480 cases havebeen genetically diagnosed. The most frequent genetic causes of MRCD in Japan are MT-TL1, MT-ATP6, PDHA1,ECHS1, and MT-ND6. Cases with younger onset are more likely to be caused by mutations in nuclear genes.Recently, novel nuclear genes such as GTPBP3, IARS and ATAD3 have been reported to cause MRCD. We arenow aware that MRCD may be the cause of many diseases in children, including cardiomyopathies, neonatal fatalhyperlactatemia, and hepatopathies. Neonatal-onset mitochondrial disease is defined as any MRCD with onsetin the neonatal period. Since initial symptoms often appear within the first two days of life, MRCD should besuspected in any neonates not doing well in this period. Mitochondrial nephropathy is also gaining attention, andit can be suspected by a characteristic pathological finding called granular swollen epithelial cells. Large-scaleepidemiologic studies have revealed outcomes and risk factors for mitochondrial cardiomyopathies, neonatalonset mitochondrial disease, and Leigh disease. With genetic analysis of MRCD now covered by public healthinsurance, research is expected to accelerate even more in the near future.Keywords
This publication has 22 references indexed in Scilit:
- ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolismBrain, 2017
- Treatable mitochondrial diseases: cofactor metabolism and beyondBrain, 2016
- Biallelic IARS Mutations Cause Growth Retardation with Prenatal Onset, Intellectual Disability, Muscular Hypotonia, and Infantile HepatopathyThe American Journal of Human Genetics, 2016
- Mutations in GTPBP3 Cause a Mitochondrial Translation Defect Associated with Hypertrophic Cardiomyopathy, Lactic Acidosis, and EncephalopathyThe American Journal of Human Genetics, 2014
- Mitochondrial encephalomyopathies—Fifty years onNeurology, 2013
- A guide to diagnosis and treatment of Leigh syndromeJournal of Neurology, Neurosurgery & Psychiatry, 2013
- The Mitochondrial Proteome and Human DiseaseAnnual Review of Genomics and Human Genetics, 2010
- Granular Swollen Epithelial Cells: A Histologic and Diagnostic Marker for Mitochondrial NephropathyAmerican Journal of Surgical Pathology, 2010
- Nuclear DNA origin of cytochrome c oxidase deficiency in Leigh's syndrome: genetic evidence based on patient's-derived rho transformantsHuman Molecular Genetics, 1995
- SUBACUTE NECROTIZING ENCEPHALOMYELOPATHY IN AN INFANTJournal of Neurology, Neurosurgery & Psychiatry, 1951